Publication:

Imprudent use of proton pump inhibitors in current practice

In a developing country like India, where over 500 branded formulations of PPI are available, probability of misuse and abuse increases exponentially. Although a safe and very effective class of pharmaceutical agent, PPIs should be used only when there is documented evidence of a GI disorder that cannot be treated with an H2-receptor antagonist, and where a PPI use is clinically justified. Increased clinician awareness on appropriate PPI prescription will lead to better patient outcome at lower cost.